MSV-allo

Developed for: pneumonia
Investigated by: Castilla-León Health Service · Citospin · Hospital del Rio Hortega · Instituto de Salud Carlos III · Red de Terapia Celular · University of Valladolid

today NCT04361942 · Ph 2

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT04361942	May 2020 → Oct 2021	pneumonia	Red de Terapia Celular	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	MSV-allo	“Double Blind, Placebo-controlled, Phase I/II Clinical Trial to Evaluate Safety and Efficacy of Allogeneic Mesenchymal Stem/Stromal Cells MSV-allo for Treatment of Acute...” NCT04361942 ↗